Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wiskott-Aldrich Syndrome”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Testing effectiveness (Phase 2)UnknownNCT03019809
What this trial is testing

A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients

Who this might be right for
Wiskott-Aldrich SyndromeHematopoietic Stem Cell TransplantationGraft Failure
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Testing effectiveness (Phase 2)Ended earlyNCT00909363
What this trial is testing

Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients

Who this might be right for
Wiskott-Aldrich SyndromeThrombocytopeniaBleeding
Weill Medical College of Cornell University 24
Large-scale testing (Phase 3)Study completedNCT00220766
What this trial is testing

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

Who this might be right for
Immunologic Deficiency SyndromeAgammaglobulinemiaSevere Combined Immunodeficiency+2 more
Grifols Therapeutics LLC 100
Testing effectiveness (Phase 2)Enrolling By InvitationNCT01852370
What this trial is testing

Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases

Who this might be right for
Severe Combined Immunodeficiency (SCID)Immunodeficiency With Predominant T-cell Defect, UnspecifiedSevere Chronic Neutropenia+6 more
Paul Szabolcs 16
Testing effectiveness (Phase 2)Ended earlyNCT02512679
What this trial is testing

Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells

Who this might be right for
Stem Cell TransplantationBone Marrow TransplantationPeripheral Blood Stem Cell Transplantation+10 more
Children's Hospital Los Angeles 20
Testing effectiveness (Phase 2)Study completedNCT01347242
What this trial is testing

Gene Therapy for Wiskott-Aldrich Syndrome (WAS)

Who this might be right for
Wiskott-Aldrich Syndrome
Genethon 6
Not applicableStudy completedNCT04429568
What this trial is testing

THC Crossover Study

Who this might be right for
THCCannabisCannabis Smoking+6 more
University of California, San Francisco 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT02333760
What this trial is testing

Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome
Genethon 10
Testing effectiveness (Phase 2)Study completedNCT01515462
What this trial is testing

Gene Therapy for Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome (WAS)
Fondazione Telethon 8
Not applicableLooking for participantsNCT04528355
What this trial is testing

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more
Paul Szabolcs 50
Early research (Phase 1)Study completedNCT00774358
What this trial is testing

Interleukin-2 Treatment for Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome (WAS)X-linked Thrombocytopenia
Soma Jyonouchi 9
Post-approval studies (Phase 4)Study completedNCT01289847
What this trial is testing

Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency

Who this might be right for
Primary Immune Deficiency DisordersCommon Variable ImmunodeficiencyX-linked Agammaglobulinemia+2 more
Bio Products Laboratory 25
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Testing effectiveness (Phase 2)Study completedNCT00919503
What this trial is testing

Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

Who this might be right for
Non-Neoplastic Hematologic and Lymphocytic Disorder
Fred Hutchinson Cancer Center 98
Not applicableStudy completedNCT01953016
What this trial is testing

Participation in a Research Registry for Immune Disorders

Who this might be right for
Primary ImmunodeficienciesAPECEDCGD+2 more
National Human Genome Research Institute (NHGRI) 716
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Large-scale testing (Phase 3)Study completedNCT00278954
What this trial is testing

Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.

Who this might be right for
Primary ImmunodeficiencyCommon Variable HypogammaglobulinemiaX-linked Hypogammaglobulinemia+3 more
Bio Products Laboratory 50
Not applicableActive Not RecruitingNCT01652092
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies

Who this might be right for
SCIDOmenn's SyndromeReticular Dysgenesis+11 more
Masonic Cancer Center, University of Minnesota 57
Testing effectiveness (Phase 2)Study completedNCT01347346
What this trial is testing

Gene Therapy for WAS

Who this might be right for
Wiskott-Aldrich Syndrome
Genethon 5
Early research (Phase 1)Study completedNCT00744692
What this trial is testing

Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders

Who this might be right for
Non Malignant DisordersImmunodeficienciesCongenital Marrow Failures+5 more
Duke University 22
Load More Results